Envestnet Asset Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.91M | Buy |
82,206
+25,634
| +45% | +$1.35M | ﹤0.01% | 2510 |
|
|
2025
Q4 | $2.97M | Sell |
56,572
-13,817
| -20% | -$827K | ﹤0.01% | 2539 |
|
|
2025
Q3 | $4.56M | Buy |
70,389
+2,447
| +4% | +$140K | ﹤0.01% | 2311 |
|
|
2025
Q2 | $3.3M | Sell |
67,942
-116
| -0.2% | -$4.49K | ﹤0.01% | 2489 |
|
|
2025
Q1 | $2.32M | Buy |
68,058
+12,025
| +21% | +$510K | ﹤0.01% | 2626 |
|
|
2024
Q4 | $2.21M | Buy |
56,033
+1,256
| +2% | +$59.3K | ﹤0.01% | 2631 |
|
|
2024
Q3 | $2.57M | Buy |
54,777
+14,131
| +35% | +$717K | ﹤0.01% | 2502 |
|
|
2024
Q2 | $2.2M | Sell |
40,646
-671
| -2% | -$38.8K | ﹤0.01% | 2544 |
|
|
2024
Q1 | $2.82M | Buy |
41,317
+1,930
| +5% | +$138K | ﹤0.01% | 2359 |
|
|
2023
Q4 | $2.47M | Buy |
39,387
+10,767
| +38% | +$595K | ﹤0.01% | 2335 |
|
|
2023
Q3 | $1.3M | Buy |
28,620
+10,607
| +59% | +$548K | ﹤0.01% | 2619 |
|
|
2023
Q2 | $1.01M | Sell |
18,013
-1,527
| -8% | -$86.6K | ﹤0.01% | 2738 |
|
|
2023
Q1 | $884K | Sell |
19,540
-4,945
| -20% | -$240K | ﹤0.01% | 2759 |
|
|
2022
Q4 | $995K | Buy |
24,485
+2,643
| +12% | +$140K | ﹤0.01% | 2648 |
|
|
2022
Q3 | $1.43M | Buy |
21,842
+14
| +0.1% | +$1.01K | ﹤0.01% | 2291 |
|
|
2022
Q2 | $1.33M | Buy |
21,828
+2,739
| +14% | +$161K | ﹤0.01% | 2379 |
|
|
2022
Q1 | $1.2M | Buy |
19,089
+2,668
| +16% | +$168K | ﹤0.01% | 2543 |
|
|
2021
Q4 | $1.24M | Buy |
16,421
+566
| +4% | +$49.4K | ﹤0.01% | 2480 |
|
|
2021
Q3 | $1.77M | Sell |
15,855
-5,736
| -27% | -$720K | ﹤0.01% | 2164 |
|
|
2021
Q2 | $3.5M | Buy |
21,591
+5,656
| +35% | +$688K | ﹤0.01% | 1725 |
|
|
2021
Q1 | $1.94M | Buy |
15,935
+6,457
| +68% | +$975K | ﹤0.01% | 1954 |
|
|
2020
Q4 | $1.45M | Buy |
9,478
+5,452
| +135% | +$644K | ﹤0.01% | 1967 |
|
|
2020
Q3 | $337K | Buy |
+4,026
| New | +$357K | ﹤0.01% | 2682 |
|
Other funds holding CRSP
AIM
OAG
GP
SOCM
